Clinical Trial Update: Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing travoprost 0.004%/timolol 0.5% versus latanoprost 0.005%/timolol 0.5% in Chinese patients with open-angle glaucoma or ocular hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost 0.005%/Timolol 0.5% fixed-dose combination (latanoprost/timolol)
• Travoprost 0.004%/Timolol 0.5% fixed-dose combination (travoprost/timolol)

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED